Blackstone’s RayzeBio RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-108,090
Closed -$6.72M – 200
2023
Q4
$6.72M Buy
108,090
+8,090
+8% +$201K 0.03% 83
2023
Q3
$2.22M Buy
+100,000
New +$2.1M 0.01% 107

Blackstone's RYZB Position: Q1 2024 in Review

Blackstone sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 108,090 shares — an estimated $6.72M sold.

Blackstone first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $6.72M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Blackstone reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
  • Blackstone sold 108,090 RayzeBio shares in Q1 2024, an estimated $6.72M.
  • Blackstone first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
  • Blackstone's RayzeBio position peaked at $6.72M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.

Based on Blackstone's 13F filing for Q1 2024, filed 15 May 2024.